Orientations

Pneumococcal Vaccine: Handling the change in product manufacturer and presentation

Summary guidance for national authorities and immunization programme managers for the switch from GlaxoSmithKline Biologicals SA Synflorix® (PCV 10) to Pfizer Prevenar13® vaccine (PCV 13)

Langues

  • Portuguais

Année de publication

2017

Was this useful?
Log in to vote

Ajouté par: Géraldine Nemrod

Ajouté le: 2020-10-28 01:58:53

Consultations: 2412

Fichier téléchargé

PneumococcalVaccineSwitchNote_March2016FINAL.zip

Cliquez pour télécharger